Related Experiment Video
Updated: Apr 26, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience
Emily I Schindler1, Patricia Sellenriek2, Gregory A Storch3
1Barnes Jewish Hospital, St. Louis, Missouri, USA Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Insights
Detecting Shiga toxin-producing E. coli (STEC) in children requires both sorbitol-MacConkey (SMAC) agar culture and enzyme immunoassay (EIA). Relying solely on EIA misses some STEC infections, impacting clinical and public health.
Area of Science:
- Microbiology
- Clinical Diagnostics
- Infectious Diseases
Background:
- Shiga toxin-producing Escherichia coli (STEC) causes diarrheal illness, sometimes leading to hemolytic uremic syndrome (HUS).
- Accurate detection of STEC is crucial for timely clinical management and public health surveillance.
Purpose of the Study:
- To evaluate the optimal methods for detecting STEC in pediatric diarrheal illness.
- To compare sorbitol-MacConkey (SMAC) agar culture, enzyme immunoassay (EIA), and their combined use for STEC detection.
Main Methods:
- Retrospective analysis of stool specimens from children with diarrhea.
- Comparison of STEC detection rates using SMAC agar culture, Shiga toxin EIA, and both methods concurrently.
Main Results:
- STEC was detected in 0.7% of specimens; E. coli O157 was the most common serotype.
- Combined SMAC agar and EIA detected 88% of E. coli O157 cases; EIA alone missed 9% of cases.
- In HUS cases, STEC was isolated in 50% of patients, with E. coli O157 being predominant.
Conclusions:
- A subset of E. coli O157 infections are missed if agar-based methods are excluded.
- Concomitant use of SMAC agar culture and Shiga toxin EIA is the best practice for STEC detection.
- Shiga toxin EIA alone is insufficient for detecting E. coli O157 in clinical samples.
Abstract:
The aim of this study was to identify the best practices for the detection of Shiga toxin-producing Escherichia coli (STEC) in children with diarrheal illness treated at a tertiary care center, i.e., sorbitol-MacConkey (SMAC) agar culture, enzyme immunoassay (EIA) for Shiga toxin, or the simultaneous use of both methods. STEC was detected in 100 of 14,997 stool specimens submitted for enteric culture (0.7%), with 65 cases of E. coli O157. Among E. coli O157 isolates, 57 (88%) were identified by both SMAC agar culture and EIA, 6 (9%) by SMAC agar culture alone, and 2 (3%) by EIA alone. Of the 62 individuals with diarrheal hemolytic uremic syndrome (HUS) seen at our institution during the study period, 16 (26%) had STEC isolated from cultures at our institution and 15 (24%) had STEC isolated at other institutions. No STEC was recovered in 31 cases (50%). Of the HUS cases in which STEC was isolated, 28 (90%) were attributable to E. coli O157 and 3 (10%) were attributable to non-O157 STEC. Consistent with previous studies, we have determined that a subset of E. coli O157 infections will not be detected if an agar-based method is excluded from the enteric culture workup; this has both clinical and public health implications. The best practice would be concomitant use of an agar-based method and a Shiga toxin EIA, but a Shiga toxin EIA should not be considered to be an adequate stand-alone test for detection of E. coli O157 in clinical samples.
Related Concept Videos
Bacterial Gastroenteritis
Cholera
Stringent Response in E. coli
Bacterial Toxins
Investigation of Disease Outbreaks

